Your Search Returned 125 tagged news reports
PPI not needed for occasional heartburn Anthony L...Ask Dr. K Posted: 05/31/2013 12:00:32 AM PDT Updated: 05/31/2013 12:00:32 AM PDT Dear Dr. K: I've been taking Prilosec for years to prevent heartburn. My wife doesn't think it's safe to take any
Tags:
Standard & Poor's cut its credit outlook for AstraZeneca to negative from stable on Monday in response to a major strategy update by the drugmaker's new chief executive last month. The ratings agency said it did not believe the new strategy would
Tags:
March 31, 2013 Nietzsche, the German philosopher, wrote, The belly is the main reason why man does not mistake himself for a god...It should also remind us that ignoring this common symptom could also be dangerous...The National Institute of Diabetes
Tags:
Since we looked at AstraZeneca last year , the company has lost a point, as dividend growth slipped below the 10% mark. The stock has also struggled, posting roughly break-even results over the past year. AstraZeneca has many of the attractive
Tags:
Big Pharma in Survival Mode At first glance, a company making nearly $28 billion in revenue and $6.3 billion in profit doesn't seem to fit the description of being in survival mode. AZN ) finds itself. Sales for antipsychotic drug Seroquel IR
Tags:
The concomitant therapy contains proton pump inhibitor (lansoprazole, omeprazole, rabeprazole sodium and esomeprazole magnesium hydrate, generic name), amoxicillin hydrate, and either clarithromycin or metronidazole. H. pylori gastritis, thought to
Tags:
An implanted magnetic device could offer a new treatment option for people with chronic heartburn that is not controlled with medication, a small study suggests...For people who have frequent heartburn -- more than twice a week -- the go-to
Tags:
Leo Burnett's Chicago, London, Paris and Berlin offices all participated in a pitch for the over-the-counter business, with support from Publicis Healthcare Communications Group...Leo Burnett will lead the account out of its Chicago headquarters, but
Tags:
AstraZeneca has admitted it faces another difficult year of falling sales in 2013 after patent expiries last year meant revenues slumped 17 per cent to £27.9bn. Pascal Soriot, the new chief executive of Britain's second-biggest drug maker, was
Tags:
FDA Orange Book, company 10-Ks. How steep is the cliff? Plavix posted Q3 2012 sales of $64 million, a whopping loss of 96% over the previous quarter...Lipitor sold $749 million worth of cholesterol-fighting power in the same quarter, a decline of
Tags: